Explore By Subject Area   
Return Home
Menu

Lead Podcast

Lessons Learned in the Development and Introduction of Closed Loop Systems

Lessons Learned in the Development and Introduction of Closed Loop Systems

Technological advances in closed-loop drug-device delivery systems that improve patient experience and lead to clinical adoption in diabetes, oncology and neurology with representatives from Abbott, Novo Nordisk, Key Tech, Beta Bionics and MIT.

Learn More

Featured Podcasts

Bispecific Antibodies for PD-1 and VEGF: Impact and Market Dynamics for IO Landscape

Listen

The Life-Changing Power of a Clinical Trial, from a Caregiver's Perspective

Listen

Navigating Data Quality and Scalability Challenges when Using Real-World Data from EHRs

Listen

Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution

Listen

Best Practices and Potential Pitfalls Enriching Clinical Trials with PROs

Listen

Podcasts by Category

Modernizing Clinical Trial Operations

View All
Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform
Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform
How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost
Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives
Biogen Pilot on Using Vocal Biomarkers to Identify Potential Trial Participants: From the DPHARM 2024 Archives
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives

Immuno-Oncology and Cell Therapy

View All
Understanding the Immunological Effects of Radiopharmaceuticals
Understanding the Immunological Effects of Radiopharmaceuticals
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma
What to Expect at the 2026 IO360° Summit
What to Expect at the 2026 IO360° Summit
Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs
Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

Drug Delivery

View All
Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics
Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics
Balancing Between Concentration and Volume when Developing Patient-Centric Biologics
Balancing Between Concentration and Volume when Developing Patient-Centric Biologics
Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches
Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches
Directors' Talk PODD 2025 - Keynotes & Key Themes
Directors' Talk PODD 2025 - Keynotes & Key Themes

Patients as Partners in Clinical Research and Patient Access

View All
J&J Office of the Chief Medical Officer on Integrating Patient Centricity Across the Enterprise
J&J Office of the Chief Medical Officer on Integrating Patient Centricity Across the Enterprise
The Role of Patient Organizations in Increasing Representation at the Clinical Trial Site Level
The Role of Patient Organizations in Increasing Representation at the Clinical Trial Site Level
Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
Ensuring Continuity in Patient Insights to Strengthen Medicine Development
Ensuring Continuity in Patient Insights to Strengthen Medicine Development

Biotech CMO/R&D Leadership

View All
CMOs Working Flexibly with Consultants and Fractional Expertise
CMOs Working Flexibly with Consultants and Fractional Expertise
Optimizing the Value Proposition in Small Companies with Limited Budgets
Optimizing the Value Proposition in Small Companies with Limited Budgets
De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing
De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing
Sponsored
How Biopharma CMOs Can Better Partner with Patient Organizations
How Biopharma CMOs Can Better Partner with Patient Organizations

Community-Based Clinical Trials

View All
Insights from Tufts CSDD Into Evolving Trial Partnerships Models
Insights from Tufts CSDD Into Evolving Trial Partnerships Models
How to Embed Clinical Research in Rural and Frontier Health Systems
How to Embed Clinical Research in Rural and Frontier Health Systems
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges
Joint Site and Sponsor Perspectives on Innovative Solutions Addressing Sites Challenges

Women Leadership in Biotech

View All
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
Accelerating Patient Enrollment in Clinical Trials by Deploying a Product Model Approach, from DPHARM 2024 Archives
Ensuring Continuity in Patient Insights to Strengthen Medicine Development
Ensuring Continuity in Patient Insights to Strengthen Medicine Development
Stanford's Dr Crystal Mackall on CAR T for Solid Tumors and Cell Therapy's Future, from IO360º 2025
Stanford's Dr Crystal Mackall on CAR T for Solid Tumors and Cell Therapy's Future, from IO360º 2025
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.